Featured News

Sep 17, 2019
Big data, bench science suggests drug may slow Parkinson disease progression in people
Drug used to treat enlarged prostate appears to improve Parkinson disease symptoms in experimental models and human database analysis.
Sep 16, 2019
Commonly used drug for Alzheimer disease doubles risk of hospitalization
Drug commonly used to manage symptoms of Alzheimer disease and other dementias associated with a 2-fold higher risk of hospital admission for rhabdomyolysis compared with several other cholinesterase inhibitors.
Sep 12, 2019
Gene therapy helps functional recovery after stroke
New gene therapy turns glial cells into neurons, repairing damage that results from stroke and significantly improving motor function in mice.
Sep 11, 2019
Brain changes may help track dementia, even before diagnosis
Results suggest that changes in brain network connections could potentially be used to track early changes in Alzheimer disease and cerebrovascular disease.
Sep 10, 2019
Repetitive impacts key to understanding sports-associated concussions
Study indicates repetitive impacts - as opposed to single events - cause the all-important damage to blood vessels in the brain.
Sep 09, 2019
High blood pressure treatment may slow cognitive decline
High blood pressure appears to accelerate cognitive decline among middle-aged and older adults, but treating high blood pressure may slow this down.
Sep 06, 2019
Apathy as an indicator of progression in Huntington disease
Researchers associate changes in white matter connectivity in different subtypes of apathy, one of the most common psychiatric syndromes in Huntington disease.
Sep 05, 2019
Study links hearing aids to lower risk of dementia, depression and falls
Study of Medicare HMO participants, whose insurance covers part of hearing aid cost, reveals disparities in use and difference in incidence of major conditions after 3 years.
Sep 04, 2019
Why do some people stop breathing after seizures?
New study finds that serotonin may provide a clue.
Sep 03, 2019
Neurobiological mechanisms behind schizophrenia may depend on gender
Mechanisms involved in the development of schizophrenia differ at least partially between males and females, and these differences may matter in the choice of treatment.
Next ▶